White label ELPA - ClinicalTrials.eu

Study on the Safety and Tolerance of BI 907828 in Patients with Advanced Dedifferentiated Liposarcoma

Not recruiting

3 1 1
Investigated Diseases:
- Dedifferentiated liposarcoma
Investigated Drugs:
- (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Not recruiting

3 1
Investigated Diseases:
- Psoriatic arthropathy
Investigated Drugs:
- Guselkumab
+5
Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

Not recruiting

3 1 1
Investigated Diseases:
- Biliary cancer metastatic
- Biliary neoplasm
Investigated Drugs:
+2
Study on Long-Term Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Fragile X syndrome
Investigated Drugs:
- Cannabidiol
Study on L19TNF and Doxorubicin for Patients with Advanced or Metastatic Soft Tissue Sarcoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Soft tissue sarcoma
Investigated Drugs:
- Onfekafusp Alfa
- Doxorubicin Hydrochloride
Study on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy

Not recruiting

2 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
Investigated Drugs:
- Cetrelimab
- Gemcitabine Hydrochloride
Study of Zolbetuximab Alone and with Drug Combination for Patients with Advanced Stomach or Gastroesophageal Junction Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
- Oesophageal adenocarcinoma
Investigated Drugs:
Study on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease

Not recruiting

2 1 1
Investigated Diseases:
- Acute graft versus host disease in intestine
Investigated Drugs:
- Apraglutide
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer

Not recruiting

1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Capmatinib
- Amivantamab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies